FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy

Some cases of nephrotic syndrome in focal and segmental glomerulosclerosis (FSGS) are associated with a circulating factor, the FSGS permeability factor (FSPF). Galactose has a high affinity for FSPF, and experimental data suggest that it could reduce its activity. We describe the case of a 48-year-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2009-09, Vol.24 (9), p.2938-2940
Hauptverfasser:	De Smet, Eric, Rioux, Jean-Philippe, Ammann, Hélène, Déziel, Clément, Quérin, Serge
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Proteins - metabolism Creatinine - blood Emergency and intensive care: renal failure. Dialysis management focal segmental galactose Galactose - administration & dosage Galactose - therapeutic use Glomerulonephritis glomerulosclerosis Glomerulosclerosis, Focal Segmental - blood Glomerulosclerosis, Focal Segmental - complications Humans Intensive care medicine Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure nephrotic syndrome Nephrotic Syndrome - blood Nephrotic Syndrome - drug therapy Nephrotic Syndrome - etiology permeability factor Proteinuria - blood Proteinuria - drug therapy Proteinuria - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!